Instructor in Medicine, Dana-Farber Cancer Institute

Oncology

Sara Tolaney practices Oncology. She studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care Sara M. Tolaney is a published doctor as well. She has 22 publications published. The latest was: Randomized trial of a physical activity intervention in women with metastatic breast cancer. She accepts all Medicare patients.

Publications

---

• Randomized trial of a physical activity intervention in women with metastatic breast Cancer.
• Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast Cancer: incidence and risk factors.
• Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
• Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast Cancer patients.
• Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negativ...
• Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic ...
• Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast Cancer.
• Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic Breast ca...
• Breast Cancer chemotherapy and your heart.
• Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast Cancer.
• New HER2-positive targeting agents in clinical practice.
• A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast Cancer.
• Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2-Dependent and Other Solid Tumors.
• Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer.
• Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.
• Personalized medicine in breast Cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.
• A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast Cancer.
• A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ova...
• Lymphopenia associated with adjuvant anthracycline/ taxane regimens.
• Sarcoidosis mimicking metastatic breast Cancer.
• Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast Cancer.

Schools

---

• University Of California San Francisco School Of Medicine

• Johns Hopkins University

• Johns Hopkins

• Dana Farber Canc Institute

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Adrenal Gland Cancer
• Anemia
• Bladder Cancer
• Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Education

---

• Brigham and Women's Hospital
• Johns Hopkins University
• University of California San Francisco School of Medicine

Hospital

---

• Brigham and Women's Hospital
• Massachusetts General Hospital
• Dana-Farber Cancer Institute

Drug Facts

---

NPI NUMBER		1962487330
NPPES Provider LastName		TOLANEY
NPPES Provider FirstName		SARA
NPPES Provider ZIPCode		02114
NPPES Provider State		MA
Specialty Description		Hematology/Oncology
Total Claim Count		172.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1962487330
Last Name Of The Provider	TOLANEY
First Name Of The Provider	SARA
View All

Similar Doctors

---

	Dr. Yoriko Saito, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason E. Faris, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark S. Stonecypher, MD
	Joan Sully, NP
	Dr. Adam S. Crystal, MD This Doctor is OpenDoctor Recommended.
	Dr. Karim E. Abou-Nassar, MD
	Dr. Jason A. Freed, MD This Doctor is OpenDoctor Recommended.
	Dr. Ramesh A. Shivdasani, MD This Doctor is OpenDoctor Recommended.
	Dr. Lawrence S. Blaszkowsky, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Douglas S. Micalizzi, MD
	Dr. Jean M. Connors, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. James W. Mier, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Caron A. Jacobson, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael S. Rabin, MD This Doctor is OpenDoctor Recommended.
	Dr. Erica L. Mayer, MD This Doctor is OpenDoctor Recommended.
	Dr. Jill N. Allen, MD
	Dr. Thomas A. Abrams, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Rachel A. Freedman, MD This Doctor is OpenDoctor Recommended.
	Dr. Douglas A. Rubinson, MD This Doctor is OpenDoctor Recommended.
	Dr. Howard K. Koh, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog